“Melanotan II is basically the same thing as Scenesse or Vyleesi, just cheaper.”

Misleading

This statement leaves out a limit that changes its meaning.

Scenesse is a clinician-placed controlled-release implant of afamelanotide, a different molecule that binds predominantly to the melanocortin-1 receptor, approved for photosensitivity in erythropoietic protoporphyria. Vyleesi is bremelanotide, approved for a defined sexual-desire disorder in certain premenopausal women. Melanotan II is neither molecule and has no approval, no label, no established dose, and no verified vial content.

What this answer is based on

This answer uses an official regulator record or a specific product label.

Limits of this answer

Both versions of the confusion: melanotan marketed as equivalent to the approved Scenesse implant, and melanotan II marketed as a cheaper route to the approved bremelanotide effect. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.

Topic

Whether evidence for one product also applies to another product.